用低分子肝素辅助治疗房颤并发脑梗死的效果评价

Effect of Low Molecular Heparin for Adjuvant therapy of Atrial Fibrillation with Cerebral Infarction

目的 :探讨用低分子肝素辅助治疗房颤并发脑梗死的临床效果。方法 :将2016年1月至2017年1月期间重庆市三峡中心医院收治的68例房颤并发脑梗死患者按随机双盲法分为阿司匹林组与肝素组,每组各有34例患者。用阿司匹林、血栓通和胞二磷胆碱对阿司匹林组患者进行治疗,用低分子肝素对肝素组患者进行治疗。治疗结束后,观察对比两组患者治疗的总有效率和神经功能缺损程度的评分。结果 :肝素组患者治疗的总有效率明显高于阿司匹林组患者,其神经功能缺损程度的评分明显低于阿司匹林组患者,差异具有统计学意义(P<0.05)。结论 :用低分子肝素辅助治疗房颤并发脑梗死可显著提升治疗的效果,改善患者的神经功能。

Objective To study theeffect of low molecular heparin for adjuvant therapy of atrial fibrillation with cerebral infarction. Methods Random selected from Sanxia Central Hospital of Changqing from January 2016 to January 2017 to receive and treat the patients of atrial fibrillation with cerebral infarction in 68 cases as the research object, and were randomly divided into Group A and Group B, 34 cases in each group. Treat group A with Aspilin,Xueshuantong and citicohne, treat group B with low molecular heparin. To compare curative effect and neurological function deficiency scale of two groups after treatment. Results The cure effective rate of group B is higher than group A but neurological function deficiency degree is lower than group A, discrepancy of research results of two groups was statistically significant （P〈 0.05）. Conclusion Treat atrial fibrillation with cerebral infarction with low molecular heparin for adjuvant therapy can improve curative effect and neurelogieal function of patients.